King Luther Capital Management Corp Inotiv, Inc. Transaction History

King Luther Capital Management Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$1.66 - $9.87 $166,000 - $986,999	100,000 Added 101.42%	198,600 $329,000
Q4 2023 Feb 09, 2024	BUY	$1.69 - $3.86 $83,317 - $190,298	49,300 Added 100.0%	98,600 $361,000
Q4 2022 Feb 13, 2023	SELL	$3.77 - $22.1 $241,430 - $1.42 Million	-64,040 Reduced 56.5%	49,300 $243,000
Q3 2022 Nov 10, 2022	BUY	$9.81 - $26.17 $490,500 - $1.31 Million	50,000 Added 78.94%	113,340 $1.91 Million
Q2 2022 Aug 11, 2022	SELL	$9.56 - $25.91 $530,341 - $1.44 Million	-55,475 Reduced 46.69%	63,340 $608,000
Q1 2022 May 11, 2022	BUY	$18.52 - $40.41 $975,818 - $2.13 Million	52,690 Added 79.68%	118,815 $3.11 Million
Q4 2021 Feb 14, 2022	BUY	$30.55 - $57.88 $939,107 - $1.78 Million	30,740 Added 86.87%	66,125 $2.78 Million
Q3 2021 Nov 10, 2021	BUY	$23.69 - $49.93 $838,270 - $1.77 Million	35,385 New	35,385 $1.04 Million

3.67M

1.1K

21.3K

Ticker NOTV
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 25,594,500
Market Cap $104M
Description
Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segme...

Get notified when there are updates to the investment portfolio of King Luther Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on King Luther Capital Management Corp with notifications on news.